| Gene Symbol | CAV1 |
| Aliases | Caveolin 1, Caveolin-1 |
| Protein Type | Structural Protein |
| Target Class | Structural Protein |
| Function | No established drugging mechanism for structural membrane protein |
| Mechanism of Action | No established drugging mechanism for structural membrane protein |
| Druggability | Low (0.35) |
| Clinical Stage | Approved |
| Molecular Weight | 22 kDa |
| Pathways | MAPK pathway, PI3K |
| UniProt ID | Q2TNI1 |
| GeneCards | CAV1 |
| Human Protein Atlas | CAV1 |
| Associated Diseases | ALS, ALZHEIMER, Anxiety, Atherosclerosis |
| Known Drugs/Compounds | Daidzein |
| Interactions | TFR1, LRP1, ABCB1, HIF1A, BECN1, CLDN5 |
| SciDEX Target | View Target Profile (1 clinical trials) |
| KG Connections | 517 knowledge graph edges |
| Databases | GeneCardsNCBI GeneHPASTRING |